Endocrine finding in tb full details for md exams 15marks with dosage and treatment

Reading Document
Medical Text Search

endocrine manifestations tuberculosis adrenal thyroid pituitary

Medical Text Search

tuberculosis treatment anti-tubercular therapy dosage regimen

GradeResponse
GradeResponse
Medical Text Search

adrenal tuberculosis Addison's disease cortisol deficiency mineralocorticoid

Medical Text Search

tuberculosis SIADH hyponatremia hypercalcemia vitamin D granuloma

I have sufficient retrieved content plus comprehensive knowledge to deliver a thorough answer. Here is the full MD exam answer:

Endocrine Findings in Tuberculosis — Full Details (MD Exam, 15 Marks)


Introduction

Tuberculosis (TB) is a systemic granulomatous infection caused by Mycobacterium tuberculosis that can involve virtually every endocrine gland through hematogenous spread, direct extension, or immune-mediated mechanisms. Endocrine involvement is often underdiagnosed and may be the dominant clinical presentation in extrapulmonary TB.

1. ADRENAL TUBERCULOSIS — Most Important Endocrine Manifestation

Pathology

  • TB is historically the most common cause of primary adrenal insufficiency (Addison's disease) worldwide, though autoimmune adrenalitis now predominates in developed countries
  • Bilateral adrenal involvement occurs via hematogenous spread
  • Caseous necrosis → fibrosis → calcification → destruction of cortex (>90% of cortex must be destroyed before insufficiency manifests)
  • Both glucocorticoid and mineralocorticoid secretion are lost (primary adrenal insufficiency)

Clinical Features

FeatureMechanism
Fatigue, weakness, weight lossCortisol deficiency
Hyperpigmentation (skin, mucosa, scars, pressure points)↑ ACTH/MSH (negative feedback lost)
Postural hypotension, salt cravingMineralocorticoid (aldosterone) deficiency
Nausea, vomiting, abdominal painCortisol deficiency
Hyponatremia, hyperkalemiaAldosterone deficiency
HypoglycemiaCortisol deficiency
EosinophiliaCortisol deficiency (loss of suppression)
Adrenal crisis (precipitated by stress)Acute cortisol + mineralocorticoid loss

Diagnosis

  • Serum cortisol (8 AM): <3 µg/dL = diagnostic; <18 µg/dL on stimulation = abnormal
  • Short Synacthen (ACTH stimulation) test: Gold standard — 250 µg cosyntropin IV/IM; measure cortisol at 0, 30, 60 min; peak <18 µg/dL = primary adrenal insufficiency
  • Plasma ACTH: Elevated (>2× upper limit) in primary AI
  • Serum electrolytes: Hyponatremia, hyperkalemia
  • CT abdomen: Bilateral adrenal enlargement (active TB) → later bilateral calcification (pathognomonic of old TB)
  • Adrenal biopsy (if needed): Caseating granulomas, AFB

Treatment — Adrenal TB

A. Antitubercular Therapy (ATT)
Standard 6-month regimen (2HRZE/4HR):
PhaseDrugsDuration
Intensive phaseIsoniazid (H) + Rifampicin (R) + Pyrazinamide (Z) + Ethambutol (E)2 months
Continuation phaseIsoniazid (H) + Rifampicin (R)4 months
Daily Doses (Adult, weight-based):
DrugDaily DoseMax Dose
Isoniazid (H)5 mg/kg/day300 mg/day
Rifampicin (R)10 mg/kg/day600 mg/day
Pyrazinamide (Z)25 mg/kg/day2000 mg/day
Ethambutol (E)15 mg/kg/day1600 mg/day
Note: Rifampicin significantly induces CYP3A4 and accelerates cortisol metabolism — hydrocortisone dose may need to be increased by 2–3× during rifampicin therapy.
B. Hormone Replacement Therapy (MANDATORY — lifelong)
Glucocorticoid replacement:
DrugDoseTiming
Hydrocortisone (preferred)15–20 mg in AM + 5–10 mg in early PMMimics diurnal rhythm
Prednisolone (alternative)5 mg AM + 2.5 mg PMOnce/twice daily
Mineralocorticoid replacement (primary AI):
DrugDose
Fludrocortisone50–200 µg/day orally
Sick day rules:
  • Minor illness/fever: Double glucocorticoid dose
  • Major illness/surgery: Hydrocortisone 50–100 mg IV/IM q6–8h (stress dosing)
  • Adrenal crisis: Hydrocortisone 100 mg IV bolus → 50–100 mg IV q6–8h + IV normal saline 1L in 1st hour + glucose

2. SIADH (Syndrome of Inappropriate ADH Secretion)

Mechanism

  • Pulmonary TB → ectopic ADH production from lung tissue or hypothalamic stimulation
  • Tuberculous meningitis → direct hypothalamic/pituitary involvement
  • Result: Free water retention → dilutional hyponatremia (euvolemic)

Features

  • Hyponatremia (Na⁺ <135 mEq/L), serum hypo-osmolality (<275 mOsm/kg)
  • Urine Na⁺ >20 mEq/L, urine osmolality >100 mOsm/kg (inappropriately concentrated)
  • Normal/expanded plasma volume (no edema, no dehydration)
  • Neurological symptoms: headache, confusion, seizures (if Na⁺ <120 mEq/L)

Treatment

  • Treat underlying TB (ATT as above) — SIADH resolves with treatment
  • Fluid restriction: 800–1000 mL/day (first-line for mild-moderate SIADH)
  • For severe/symptomatic hyponatremia (Na⁺ <120 or seizures): Hypertonic saline (3% NaCl) IV — correct Na⁺ at rate ≤8–10 mEq/L per 24 hours (to prevent osmotic demyelination syndrome)
  • Demeclocycline 300–600 mg BD (blocks ADH at collecting duct) — if fluid restriction fails

3. HYPERCALCEMIA

Mechanism

  • Activated macrophages in TB granulomas express 1-α hydroxylase (CYP27B1) → converts 25-OH vitamin D to 1,25-(OH)₂ vitamin D (calcitriol) in an unregulated fashion (not subject to normal feedback)
  • ↑ Calcitriol → ↑ intestinal calcium absorption + ↑ bone resorption → hypercalcemia
  • Granulomatous hypercalcemia: seen in ~10% of TB patients; hypercalciuria more common

Features

  • "Bones, stones, groans, psychic moans" (hypercalcemia symptoms)
  • Polyuria, polydipsia (nephrogenic DI from hypercalcemia)
  • Nephrolithiasis, nephrocalcinosis
  • Low PTH (suppressed), elevated calcitriol

Treatment

  • ATT (primary treatment — resolves hypercalcemia as granulomas heal)
  • Hydration: IV normal saline 200–300 mL/hour
  • Glucocorticoids: Prednisolone 40–60 mg/day (inhibit macrophage 1-α hydroxylase) — highly effective in granulomatous hypercalcemia
  • Avoid: Calcium supplements, vitamin D, thiazide diuretics, sunlight exposure (all worsen hypercalcemia)
  • Bisphosphonates if refractory

4. THYROID INVOLVEMENT

Mechanisms & Types

TypeDetails
Tuberculous thyroiditisRare; direct mycobacterial infection of thyroid; presents as cold abscess or thyroid mass
Transient thyrotoxicosisGranulomatous destruction → release of preformed thyroid hormone
HypothyroidismDestruction of thyroid tissue by caseating granuloma
Drug-induced hypothyroidismPAS (para-aminosalicylic acid — second-line ATT) inhibits thyroid peroxidase
Non-thyroidal illness (sick euthyroid)↓ T3, ↓/normal T4, ↓ TSH — in severe TB; not true hypothyroidism

Diagnosis

  • TFTs: TSH, Free T3, Free T4
  • Thyroid ultrasound/FNAC: Caseating granulomas, AFB on ZN stain
  • Cold nodule on scintigraphy

Treatment

  • ATT is primary treatment for tuberculous thyroiditis
  • Transient thyrotoxicosis: Beta-blocker (propranolol 40–80 mg TDS) for symptom relief; antithyroid drugs NOT effective (no hypersynthesis)
  • PAS-induced hypothyroidism: Levothyroxine 25–50 µg/day titrated up; stop PAS if feasible

5. PITUITARY AND HYPOTHALAMIC TB

Pathology

  • Hematogenous seeding or extension from tuberculous meningitis
  • Tuberculoma in sella turcica or suprasellar region
  • Basal meningitis → infundibular involvement

Clinical Features

Axis AffectedManifestation
ADH (most common)Central Diabetes Insipidus (DI) — polyuria, polydipsia, hypernatremia
ACTHSecondary adrenal insufficiency (no hyperpigmentation, aldosterone relatively preserved)
TSHCentral hypothyroidism — low FT4, inappropriately normal/low TSH
Gonadotropins (FSH/LH)Hypogonadotropic hypogonadism — amenorrhea, infertility, ↓ libido
GHGrowth hormone deficiency — short stature (children), metabolic syndrome (adults)
ProlactinHyperprolactinemia (stalk compression → loss of dopamine inhibition) → galactorrhea, amenorrhea
Mass effectBitemporal hemianopia (chiasmal compression), headache

Treatment

  • ATT (6–12 months; extend to 12 months for CNS TB)
  • Central DI: Desmopressin (DDAVP):
    • Intranasal: 10–40 µg/day in 1–2 divided doses
    • Oral: 0.05–1.2 mg/day
    • IV/SC: 1–4 µg/day
  • Hormone replacement: Replace each deficient axis individually (as above)
  • Corticosteroids for CNS TB: Dexamethasone 0.4 mg/kg/day for 2 weeks, then tapered over 4 weeks (WHO recommended for TB meningitis)
  • Surgical decompression if visual compromise persists despite ATT

6. HYPOGONADISM IN TB

Mechanism

  • Systemic illness effect: Chronic inflammation suppresses GnRH → hypogonadotropic hypogonadism
  • Direct testicular/ovarian involvement: Rare; miliary TB
  • Malnutrition in TB → hypothalamic amenorrhea

Features

  • Oligomenorrhea/amenorrhea in women
  • Reduced testosterone, libido, spermatogenesis in men
  • Infertility

Treatment

  • Primarily resolves with ATT and nutritional rehabilitation
  • Hormone replacement if persistent after TB treatment

7. PANCREATIC TB AND GLUCOSE DYSREGULATION

TB and Diabetes Mellitus — Bidirectional Relationship

  • DM triples the risk of TB (impaired macrophage function, reduced T-cell immunity)
  • TB worsens glycemic control (cytokine-mediated insulin resistance, catabolic state)
  • Pancreatic TB (rare): caseous granulomas → pancreatic insufficiency

TB Drug Effects on Glucose

DrugEffect
Rifampicin↓ Sulfonylurea levels (induces CYP2C9) → worsens glycemic control
IsoniazidCan cause hyperglycemia (inhibits insulin secretion)
PyrazinamideMild hyperuricemia, occasional glucose effects

Management

  • Optimize glycemic control (target HbA1c <7–8% in TB-DM)
  • Insulin preferred during intensive phase of ATT
  • Monitor sulfonylurea/OHA efficacy if rifampicin used

8. ELECTROLYTE AND METABOLIC DISTURBANCES SUMMARY

AbnormalityMechanismFrequency
HyponatremiaSIADH, adrenal insufficiency, salt wastingCommon
HyperkalemiaPrimary adrenal insufficiency (aldosterone deficiency)With adrenal TB
HypercalcemiaGranulomatous 1-α hydroxylation~10%
HypercalciuriaSame mechanism>Hypercalcemia
HypokalemiaRifampicin-induced Fanconi syndrome (rare)Rare
HyperuricemiaPyrazinamide (inhibits urate excretion)Common with PZA use

Standard ATT Regimen — Quick Reference Card

First-Line Drugs (Daily Doses — Adult)

DrugDaily DoseKey ToxicityMonitoring
Isoniazid (H)5 mg/kg (max 300 mg)Hepatotoxicity, peripheral neuropathyLFTs, add pyridoxine 25 mg/day
Rifampicin (R)10 mg/kg (max 600 mg)Hepatotoxicity, drug interactions, orange urineLFTs, drug interactions
Pyrazinamide (Z)25 mg/kg (max 2 g)Hepatotoxicity, hyperuricemia, arthralgiaUric acid, LFTs
Ethambutol (E)15 mg/kg (max 1.6 g)Optic neuritis (color vision, acuity)Monthly visual acuity testing

Regimen Duration by Site

TB SiteRegimenDuration
Pulmonary, lymph node2HRZE / 4HR6 months
Adrenal, abdominal2HRZE / 4HR6 months
Bone, joint2HRZE / 4HR9 months
CNS (meningitis, tuberculoma)2HRZE / 10HR + dexamethasone12 months
Miliary TB2HRZE / 4HR6 months

Key Points for MD Exam

  1. Adrenal TB is the most important endocrine manifestation; TB was historically the leading cause of Addison's disease worldwide.
  2. Bilateral adrenal calcification on CT is pathognomonic of healed adrenal TB.
  3. Rifampicin accelerates cortisol metabolism via CYP3A4 — hydrocortisone dose must be increased during ATT.
  4. SIADH occurs in pulmonary TB and TB meningitis — hyponatremia is the most common electrolyte abnormality.
  5. Hypercalcemia in TB is granulomatous — low PTH, elevated calcitriol, responds dramatically to steroids and ATT.
  6. Central DI is the most common pituitary axis affected in hypothalamic-pituitary TB.
  7. Sick euthyroid syndrome (low T3) is common in severe TB — does not require treatment; resolves with ATT.
  8. DM and TB have a bidirectional relationship; rifampicin reduces OHA efficacy.
  9. Pyridoxine (25 mg/day) must be co-administered with isoniazid to prevent peripheral neuropathy.
  10. Fludrocortisone is always needed in primary adrenal insufficiency (adrenal TB) — not in secondary (pituitary TB).

Sources: Harrison's Principles of Internal Medicine, 21st Edition (p. 10827); Treatment of Drug-Susceptible Tuberculosis — IDSA/ATS/CDC Guidelines; WHO Guidelines for Treatment of TB (2022); supplemented with core endocrinology and infectious disease knowledge.
This is a shared conversation. Sign in to Orris to start your own chat.